Value Sense

Research & Analysis — Freemium

AI stock analysis tool with intrinsic value estimates and fundamental screening

Intrinsic value scoring with backtesting built into the screener

Overview

Value Sense is an AI-driven research and analysis tool built for long-term investors who want a fast, plain read on stock valuation without building their own spreadsheets. This Value Sense review looks at what the scoring system gets right and where the public feedback raises real flags. It's aimed at beginners just getting comfortable with fundamental analysis, not professional analysts who already have their own models.

The platform scores stocks on intrinsic value and quality fundamentals, then surfaces names it reads as undervalued. That sits inside a fuller toolkit: a stock screener, fair value estimates, backtesting, earnings analysis, and company research pages built around cash flow and returns on capital. Backtesting is included directly on screener results, so you can check how a valuation filter would have performed historically before trusting it. Plans start at $15/mo for the Starter tier, and a free trial lets you test the process before paying anything.

The public record is not clean, and buyers should know that going in. Value Sense's Trustpilot score sits at 2.9, with users reporting inaccurate data, unclear sourcing on where the numbers come from, and renewal charges they say were never authorized. That's a serious complaint for a tool whose whole pitch rests on trustworthy fundamentals. Anyone signing up should read the reviews directly and use the free trial to check the data against a company they already know well before a card gets charged.

Coverage is limited to US stocks, and the tool is built for long-term investing rather than active trading, with no mobile app and no API access, so it stays manual and deskbound. Beginners chasing a quick valuation snapshot are the intended user. Day traders, options traders, and anyone who needs airtight data accuracy without double-checking the source themselves should skip this one and look for a more established research platform instead.

Pros

Cons